To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MAP3K1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
183 supporting clones for gene MAP3K1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_005921.1   .a 1 to 7509 1 to 7509 exact RefSeq, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 7509/7509
(100 %)
0 diff
(100 %id)
AF042838   .a 559 to 5248 1 to 4693   tiling clone,   4693/4693
(100 %)
35 diff
(99.3 %id)
DR006352 Prostate .a 589 to 1136 1 to 549   tiling clone,   549/554
(99 %)
7 diff
(98.8 %id)
BM148300 leukopheresis .a 912 to 1397 1 to 486       486/486
(100 %)
4 diff
(99.2 %id)
BE162514 head_neck .a 1134 to 1754 23 to 638       616/622
(99 %)
23 diff
(96.4 %id)
AW580454 head_neck .a 1135 to 1609 22 to 492       471/492
(95 %)
6 diff
(98.8 %id)
CU448210 epidermis .a 1226 to 2068 855 to 13   tiling clone, Submitted on the opposite strand 843/855
(98 %)
1 diff
(99.9 %id)
CN314482 embryonic stem cells, cell lines H1, H7, andH9 .a 1245 to 1763 1 to 519       519/519
(100 %)
0 diff
(100 %id)
CF143161 lymph .a 1494 to 2019 1 to 526       526/526
(100 %)
6 diff
(98.9 %id)
TI_154174428   .a 1501 to 2106 87 to 692       606/607
(99 %)
4 diff
(99.4 %id)
BE242824 leukopheresis .a 2219 to 2678 460 to 1       460/460
(100 %)
3 diff
(99.4 %id)
BX485112   .a 2709 to 3207 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
DA236124 brain .a 2723 to 3316 2 to 596   capped   595/595
(100 %)
3 diff
(99.5 %id)
AW499603 lymph .a 2756 to 3285 1 to 530       530/530
(100 %)
7 diff
(98.7 %id)
AW501166 lymph .a 2756 to 3175 1 to 420       420/420
(100 %)
7 diff
(98.4 %id)
CF142963 lymph .a 2756 to 3044 1 to 289       289/289
(100 %)
11 diff
(96.2 %id)
CF143770 lymph .a 2756 to 3178 1 to 423       423/431
(98 %)
9 diff
(98.0 %id)
TI_154155852   .a 2763 to 3194 81 to 512       432/433
(99 %)
3 diff
(99.4 %id)
TI_154174149   .a 2763 to 3333 89 to 660       572/1232
(46 %)
48 diff
(96.2 %id)
TI_154175301   .a 2763 to 3239 80 to 565       486/1045
(46 %)
19 diff
(98.2 %id)
TI_158439344   .a 2763 to 3447 80 to 760       681/682
(99 %)
10 diff
(98.6 %id)
AI538525 B-cell, chronic lymphotic leukemia .a 2768 to 3240 1 to 473     Submitted on the opposite strand 473/473
(100 %)
0 diff
(100 %id)
DA218151 brain .a 2775 to 3319 2 to 547   capped   546/546
(100 %)
4 diff
(99.3 %id)
BF086951 head_neck .a 2966 to 3350 395 to 11   tiling clone,   385/405
(95 %)
0 diff
(100 %id)
BE817718 breast_normal .a 3218 to 3429 17 to 228       212/237
(89 %)
11 diff
(95.4 %id)
BU172741 melanotic melanoma, skin .a 3322 to 4165 8 to 851       844/893
(94 %)
8 diff
(99.2 %id)
DA721055   .a 3396 to 3971 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
CN314481 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3645 to 4255 1 to 610       610/610
(100 %)
2 diff
(99.7 %id)
DB237837 trachea .a 3674 to 4263 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
CR989538 T-Lymphocytes .a 3691 to 4445 1 to 754   tiling clone,   754/756
(99 %)
3 diff
(99.7 %id)
BX095560 B-cell, chronic lymphotic leukemia .a 3696 to 4167 472 to 1     Submitted on the opposite strand 472/472
(100 %)
0 diff
(100 %id)
BU194120 melanotic melanoma, skin .a 4090 to 4897 48 to 862       815/895
(91 %)
15 diff
(98.4 %id)
AW502619 lymph .a 4290 to 4759 7 to 476       470/476
(98 %)
6 diff
(98.8 %id)
TI_154158165   .a 4290 to 4832 79 to 621       543/543
(100 %)
4 diff
(99.3 %id)
AL042445 testis .a 4351 to 4996 1 to 652   tiling clone,   652/653
(99 %)
11 diff
(98.4 %id)
BQ361585 ovary .a 4446 to 4606 168 to 10       159/173
(91 %)
0 diff
(100 %id)
AU132367   .a 4507 to 5344 2 to 836   capped   835/835
(100 %)
9 diff
(99.0 %id)
CV570899 cornea, eye .a 4557 to 5070 1 to 514       514/514
(100 %)
0 diff
(100 %id)
DA889202   .a 4597 to 5154 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BE075691 breast .a 4723 to 4946 1 to 224       224/224
(100 %)
1 diff
(99.6 %id)
AA809278 germinal center B cell .a 4732 to 5082 357 to 11   AAA   347/350
(99 %)
3 diff
(99.2 %id)
DA828234 placenta .a 4891 to 5553 2 to 670   tiling clone, capped   669/669
(100 %)
11 diff
(98.4 %id)
BM928438 brain .a 5036 to 5981 1 to 959   tiling clone,   959/1043
(91 %)
31 diff
(97.1 %id)
AL135609 melanoma (MeWo cell line) .a 5072 to 5541 1 to 470       470/470
(100 %)
0 diff
(100 %id)
DN915786   .a 5087 to 5649 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
BE536825 cervix .a 5112 to 5541 1 to 440       440/634
(69 %)
12 diff
(98.2 %id)
DA945972 Spleen .a 5129 to 5693 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
FN050591 breast carcinoma .a 5179 to 5266 1 to 89       89/90
(98 %)
2 diff
(97.8 %id)
FN129913 breast carcinoma .a 5228 to 5334 1 to 106       106/106
(100 %)
7 diff
(93.4 %id)
AI684800 pooled .a 5277 to 5728 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
BM153810 leukopheresis .a 5434 to 5648 1 to 215       215/215
(100 %)
13 diff
(94.0 %id)
FN057636 breast carcinoma .a 5476 to 5575 1 to 101       101/101
(100 %)
1 diff
(99.1 %id)
FN120712 breast carcinoma .a 5481 to 5540 1 to 59       59/61
(96 %)
2 diff
(96.8 %id)
AW992954 breast_normal .a 5490 to 6094 605 to 1     Submitted on the opposite strand 605/608
(99 %)
19 diff
(96.9 %id)
BP421767 small intestine .a 5532 to 6044 1 to 513   tiling clone, Submitted on the opposite strand 513/513
(100 %)
0 diff
(100 %id)
DB027822 testis .a 5586 to 6180 2 to 596   tiling clone, capped   595/595
(100 %)
2 diff
(99.7 %id)
AL133917 amygdala .a 5759 to 6469 1 to 709   tiling clone,   709/709
(100 %)
4 diff
(99.5 %id)
FN176380 breast carcinoma .a 5776 to 5873 1 to 95       95/95
(100 %)
7 diff
(92.7 %id)
DB369365   .a 6853 to 7336 485 to 1   tiling clone,   485/507
(95 %)
9 diff
(98.3 %id)
DB372698 placenta .a 7073 to 7336 265 to 1   tiling clone,   265/265
(100 %)
2 diff
(99.3 %id)
BX537527 human fetal kidney .b 1 to 3708 3 to 3709 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 3709/3710
(99 %)
14 diff
(99.7 %id)
BX498716 Liver .b 246 to 816 1 to 571       571/572
(99 %)
6 diff
(99.0 %id)
DA356595 subthalamic nucleus .b 2020 to 2288 2 to 271   capped   270/270
(100 %)
3 diff
(98.9 %id)
AA248021   .b 2048 to 2280 13 to 235   tiling clone,   223/235
(94 %)
6 diff
(97.5 %id)
BF352603 head_neck .b 2049 to 2295 247 to 1       247/252
(98 %)
6 diff
(97.7 %id)
BF216567 brain, glioblastoma .b 2056 to 2703 1 to 644       644/842
(76 %)
16 diff
(98.1 %id)
BM751575 Ascites, stomach .b 2102 to 2556 1 to 455       455/455
(100 %)
1 diff
(99.8 %id)
U56433   .b 2107 to 2530 6 to 433       428/504
(84 %)
19 diff
(96.3 %id)
FN127379 breast carcinoma .b 2139 to 2250 1 to 107       107/108
(99 %)
7 diff
(93.6 %id)
BG119132 adenocarcinoma, cell line, Liver .b 2144 to 2774 1 to 639       639/766
(83 %)
18 diff
(97.7 %id)
FN090148 breast carcinoma .b 2211 to 2311 1 to 97       97/97
(100 %)
3 diff
(97.0 %id)
FN102883 breast carcinoma .b 2331 to 2445 1 to 114       114/116
(98 %)
5 diff
(95.7 %id)
FN162502 breast carcinoma .b 2423 to 2540 116 to 1     Submitted on the opposite strand 116/116
(100 %)
6 diff
(94.9 %id)
BG426673 Kidney .b 2450 to 3232 1 to 787       787/820
(95 %)
29 diff
(96.5 %id)
BY997470   .b 2458 to 3003 10 to 553       544/553
(98 %)
6 diff
(99.0 %id)
AW967603   .b 2461 to 3003 1 to 544       544/544
(100 %)
11 diff
(98.0 %id)
AA251466 germinal center B cell .b 2461 to 2865 1 to 405       405/405
(100 %)
1 diff
(99.8 %id)
BI010310 lung_normal .b 2466 to 2742 277 to 5       273/277
(98 %)
0 diff
(100 %id)
FN055617 breast carcinoma .b 2472 to 2588 118 to 1     Submitted on the opposite strand 118/118
(100 %)
1 diff
(99.2 %id)
BF691071 melanotic melanoma, high MDR, skin .b 2473 to 3146 1 to 656       656/873
(75 %)
15 diff
(98.3 %id)
FN062988 breast carcinoma .b 2529 to 2613 1 to 85       85/87
(97 %)
4 diff
(95.5 %id)
FN094896 breast carcinoma .b 2542 to 2626 1 to 88       88/88
(100 %)
4 diff
(95.5 %id)
AW022149 cochlea, ear .b 2558 to 3044 8 to 495       488/495
(98 %)
12 diff
(97.6 %id)
AA165523   .b 2575 to 2864 1 to 294     Submitted on the opposite strand 294/294
(100 %)
5 diff
(98.3 %id)
AA166778   .b 2639 to 3203 1 to 554   tiling clone,   554/592
(93 %)
14 diff
(97.7 %id)
FN173401 breast carcinoma .b 2648 to 2763 117 to 1     Submitted on the opposite strand 117/117
(100 %)
2 diff
(98.3 %id)
FN101070 breast carcinoma .b 2674 to 2785 110 to 1     Submitted on the opposite strand 110/121
(90 %)
4 diff
(96.7 %id)
FN146537 breast carcinoma .b 2693 to 2785 1 to 89       89/90
(98 %)
4 diff
(95.6 %id)
BM703037 eye, human retina .b 2789 to 3220 1 to 429       429/429
(100 %)
1 diff
(99.8 %id)
AI298300 carcinoid, lung .b 2805 to 3200 1 to 394     Submitted on the opposite strand 394/394
(100 %)
3 diff
(99.3 %id)
AW452698   .b 2815 to 3290 476 to 3       474/476
(99 %)
0 diff
(100 %id)
DN914112   .b 2856 to 3334 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
BQ016488 lung, Metastatic Chondrosarcoma .b 2911 to 3551 640 to 1       640/640
(100 %)
5 diff
(99.3 %id)
AW972481   .b 2926 to 3534 607 to 1     Submitted on the opposite strand 607/610
(99 %)
12 diff
(98.1 %id)
TI_154173805   .b 2930 to 3549 698 to 80   AAA Submitted on the opposite strand 619/620
(99 %)
13 diff
(98.0 %id)
TI_151701018   .b 2932 to 3548 667 to 50       618/1248
(49 %)
0 diff
(100 %id)
FN053764 breast carcinoma .b 2939 to 2999 1 to 61       61/61
(100 %)
2 diff
(96.8 %id)
TI_154113289   .b 2940 to 3708 853 to 84   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 770/975
(78 %)
26 diff
(97.4 %id)
FN155850 breast carcinoma .b 2941 to 3011 1 to 70       70/70
(100 %)
1 diff
(98.6 %id)
AW050999 brain, glioblastoma (pooled) .b 2941 to 3392 1 to 448     Submitted on the opposite strand 448/551
(81 %)
21 diff
(96.2 %id)
FN050691 breast carcinoma .b 2942 to 3036 95 to 1     Submitted on the opposite strand 95/97
(97 %)
0 diff
(100 %id)
FN138838 breast carcinoma .b 2942 to 3029 86 to 1     Submitted on the opposite strand 86/88
(97 %)
4 diff
(95.5 %id)
FN094442 breast carcinoma .b 2962 to 3057 94 to 1     Submitted on the opposite strand 94/94
(100 %)
2 diff
(97.9 %id)
BQ005498 Chondrosarcoma, Left Pelvis .b 2964 to 3645 701 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 683/683
(100 %)
4 diff
(99.5 %id)
FN144499 breast carcinoma .b 2971 to 3062 88 to 1     Submitted on the opposite strand 88/88
(100 %)
4 diff
(95.5 %id)
CD676868 eye, Trabecular meshwork .b 2985 to 3535 1 to 551   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 551/551
(100 %)
2 diff
(99.7 %id)
AA541479 normal prostate, Prostate .b 2994 to 3535 539 to 1       539/593
(90 %)
14 diff
(97.7 %id)
FN132419 breast carcinoma .b 2997 to 3088 1 to 97       97/97
(100 %)
5 diff
(94.9 %id)
BX096276 placenta .b 3003 to 3708 1 to 705   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 705/705
(100 %)
2 diff
(99.8 %id)
FN146615 breast carcinoma .b 3003 to 3071 1 to 68       68/68
(100 %)
5 diff
(92.7 %id)
R79128 placenta .b 3003 to 3411 1 to 411       411/416
(98 %)
6 diff
(98.6 %id)
BQ024720 placenta .b 3003 to 3708 721 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 706/714
(98 %)
1 diff
(99.9 %id)
AI927052 Kidney .b 3004 to 3535 532 to 1       532/532
(100 %)
1 diff
(99.9 %id)
AI922124 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3008 to 3535 528 to 1       528/528
(100 %)
2 diff
(99.7 %id)
AI625811 Kidney .b 3021 to 3535 514 to 1       514/514
(100 %)
2 diff
(99.7 %id)
CF142709 lymph .b 3025 to 3549 532 to 8     Submitted on the opposite strand 525/532
(98 %)
0 diff
(100 %id)
TI_157605255   .b 3025 to 3559 602 to 68       535/602
(88 %)
0 diff
(100 %id)
BE931751 head_neck .b 3035 to 3530 509 to 16       494/509
(97 %)
0 diff
(100 %id)
AI536651 Kidney .b 3036 to 3535 500 to 1       500/500
(100 %)
2 diff
(99.6 %id)
BE645815 Prostate .b 3036 to 3535 500 to 1       500/500
(100 %)
0 diff
(100 %id)
AI804275 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3045 to 3533 489 to 1       489/489
(100 %)
0 diff
(100 %id)
FN076944 breast carcinoma .b 3050 to 3134 85 to 1     Submitted on the opposite strand 85/92
(92 %)
1 diff
(99.0 %id)
CA448770 Chondrosarcoma, Left Pelvis .b 3052 to 3708 673 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 658/658
(100 %)
11 diff
(98.4 %id)
FN118339 breast carcinoma .b 3063 to 3165 102 to 1     Submitted on the opposite strand 102/102
(100 %)
1 diff
(99.1 %id)
DN914111   .b 3065 to 3708 645 to 2       644/645
(99 %)
0 diff
(100 %id)
AI074721 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3066 to 3533 468 to 1       468/468
(100 %)
0 diff
(100 %id)
AA165567   .b 3067 to 3537 474 to 1     Submitted on the opposite strand 474/476
(99 %)
9 diff
(98.2 %id)
FN120353 breast carcinoma .b 3068 to 3167 99 to 1     Submitted on the opposite strand 99/104
(95 %)
1 diff
(99.1 %id)
AI806709 pooled .b 3072 to 3538 467 to 1       467/467
(100 %)
9 diff
(98.1 %id)
AI125918 uterus .b 3074 to 3533 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AI332426 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3097 to 3535 439 to 1       439/439
(100 %)
1 diff
(99.8 %id)
AW296750   .b 3097 to 3550 454 to 1       454/454
(100 %)
3 diff
(99.4 %id)
AW511515 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3097 to 3537 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AW572487 Kidney, renal cell tumor .b 3097 to 3550 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
BE349320 malignant melanoma, metastatic to lymphnode, skin .b 3099 to 3539 441 to 1       441/441
(100 %)
0 diff
(100 %id)
DN915787   .b 3111 to 3708 595 to 1       595/595
(100 %)
8 diff
(98.7 %id)
AA505446 breast .b 3121 to 3534 414 to 1       414/414
(100 %)
5 diff
(98.8 %id)
FN115851 breast carcinoma .b 3127 to 3230 105 to 4     Submitted on the opposite strand 102/105
(97 %)
0 diff
(100 %id)
BF964626 muscle (skeletal) .b 3134 to 3652 1 to 523       523/600
(87 %)
32 diff
(94.7 %id)
FN130756 breast carcinoma .b 3139 to 3224 1 to 87       87/87
(100 %)
1 diff
(98.9 %id)
AW235188 pooled germ cell tumors .b 3143 to 3534 392 to 1       392/392
(100 %)
0 diff
(100 %id)
FN057960 breast carcinoma .b 3147 to 3225 79 to 1     Submitted on the opposite strand 79/80
(98 %)
0 diff
(100 %id)
AI674806 Prostate .b 3170 to 3546 379 to 1       379/380
(99 %)
7 diff
(98.2 %id)
AI521181 Kidney .b 3174 to 3711 541 to 2       540/541
(99 %)
0 diff
(100 %id)
FN091762 breast carcinoma .b 3179 to 3262 80 to 1     Submitted on the opposite strand 80/80
(100 %)
4 diff
(95.0 %id)
CB160442 Liver .b 3185 to 3541 357 to 1     Submitted on the opposite strand 357/357
(100 %)
1 diff
(99.8 %id)
BE170766 head_neck .b 3187 to 3524 338 to 1     Submitted on the opposite strand 338/338
(100 %)
0 diff
(100 %id)
BE715927 head_neck .b 3196 to 3459 274 to 10       265/275
(96 %)
0 diff
(100 %id)
BP398679 pancreatic islet .b 3214 to 3640 34 to 460     Submitted on the opposite strand 427/460
(92 %)
6 diff
(98.7 %id)
AA166751   .b 3214 to 3708 489 to 1       489/629
(77 %)
12 diff
(98.1 %id)
TI_149284536   .b 3220 to 3553 54 to 387     Submitted on the opposite strand 334/1197
(27 %)
6 diff
(99.5 %id)
BU680577 lung, Primary Lung Epithelial Cells .b 3230 to 3535 1 to 306   AAA Submitted on the opposite strand 306/306
(100 %)
3 diff
(99.1 %id)
TI_149282754   .b 3232 to 3535 364 to 61   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 304/697
(43 %)
2 diff
(99.8 %id)
BU679889 lung, Primary Lung Epithelial Cells .b 3232 to 3551 320 to 1       320/345
(92 %)
2 diff
(99.5 %id)
DB551796 hippocampus .b 3240 to 3708 1 to 471     Submitted on the opposite strand 471/471
(100 %)
2 diff
(99.6 %id)
AW572284 cervix .b 3273 to 3534 262 to 1       262/262
(100 %)
0 diff
(100 %id)
C20984   .b 3284 to 3535 1 to 252       252/252
(100 %)
2 diff
(99.3 %id)
AI263934 adenocarcinoma, colon .b 3292 to 3711 426 to 7       420/426
(98 %)
0 diff
(100 %id)
AW614394 Kidney .b 3292 to 3708 420 to 1       420/420
(100 %)
1 diff
(99.8 %id)
FN060186 breast carcinoma .b 3313 to 3439 1 to 127       127/127
(100 %)
0 diff
(100 %id)
FN087319 breast carcinoma .b 3313 to 3438 126 to 1     Submitted on the opposite strand 126/126
(100 %)
0 diff
(100 %id)
FN170199 breast carcinoma .b 3320 to 3440 121 to 1     Submitted on the opposite strand 121/131
(92 %)
3 diff
(97.8 %id)
AA494032 liposarcoma .b 3326 to 3555 1 to 230       230/234
(98 %)
2 diff
(99.2 %id)
FN102038 breast carcinoma .b 3328 to 3449 1 to 118       118/118
(100 %)
4 diff
(96.7 %id)
BE041542 pooled .b 3338 to 3644 307 to 1       307/307
(100 %)
0 diff
(100 %id)
FN108439 breast carcinoma .b 3342 to 3437 1 to 97       97/98
(98 %)
2 diff
(98.0 %id)
FN051197 breast carcinoma .b 3344 to 3456 1 to 113       113/113
(100 %)
0 diff
(100 %id)
FN099083 breast carcinoma .b 3344 to 3456 1 to 109       109/109
(100 %)
4 diff
(96.4 %id)
AA602425   .b 3345 to 3711 376 to 11       366/376
(97 %)
0 diff
(100 %id)
AA831491 germinal center B cell .b 3345 to 3708 376 to 11   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 366/366
(100 %)
1 diff
(99.8 %id)
AA464694 ovarian tumor, ovary .b 3389 to 3705 317 to 1       317/317
(100 %)
0 diff
(100 %id)
FN160225 breast carcinoma .b 3398 to 3509 1 to 113       113/113
(100 %)
1 diff
(99.2 %id)
AA834992   .b 3399 to 3711 313 to 1   tiling clone,   313/313
(100 %)
0 diff
(100 %id)
AI760113 Kidney .b 3409 to 3708 302 to 1       302/302
(100 %)
1 diff
(99.7 %id)
FN060022 breast carcinoma .b 3421 to 3505 1 to 85       85/85
(100 %)
3 diff
(96.5 %id)
AA522658 metastatic prostate bone lesion .b 3433 to 3708 9 to 283   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 275/283
(97 %)
6 diff
(97.9 %id)
FN118947 breast carcinoma .b 3444 to 3525 1 to 82       82/84
(97 %)
1 diff
(98.9 %id)
FN118550 breast carcinoma .b 3452 to 3514 63 to 1     Submitted on the opposite strand 63/64
(98 %)
0 diff
(100 %id)
R79129 placenta .b 3475 to 3687 213 to 1       213/213
(100 %)
3 diff
(98.6 %id)
AA251352 germinal center B cell .b 3511 to 3708 199 to 1       199/199
(100 %)
1 diff
(99.5 %id)
FN057272 breast carcinoma .b 3558 to 3664 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
FN061880 breast carcinoma .b 3640 to 3704 1 to 66       66/71
(92 %)
2 diff
(97.2 %id)
CR743924 pooled germ cell tumors .c-u 1 to 249 1 to 252   tiling clone,   252/252
(100 %)
3 diff
(98.9 %id)
BQ883170 Spleen .c-u 126 to 906 1 to 797   tiling clone,   797/1000
(79 %)
38 diff
(96.2 %id)
AA864536 pooled germ cell tumors .c-u 809 to 1073 265 to 1 exact tiling clone,   265/265
(100 %)
0 diff
(100 %id)
AK307828 brain Gene MAP3K1, variant not shown         Suspected internal deletion, this clone was ignored    
DC322963 brain Gene MAP3K1, variant not shown         Suspected internal deletion, this clone was ignored    
AA887977 colon, colon tumor RER+ Gene MAP3K1, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI